Publications by the researcher in collaboration with ANDREA LOPEZ LOPEZ (21)

2023

  1. Interactions between Angiotensin Type-1 Antagonists, Statins, and ROCK Inhibitors in a Rat Model of L-DOPA-Induced Dyskinesia

    Antioxidants, Vol. 12, Núm. 7

2022

  1. Angiotensin Type-1 Receptor Inhibition Reduces NLRP3 Inflammasome Upregulation Induced by Aging and Neurodegeneration in the Substantia Nigra of Male Rodents and Primary Mesencephalic Cultures

    Antioxidants, Vol. 11, Núm. 2

2021

  1. An ACE2/Mas-related receptor MrgE axis in dopaminergic neuron mitochondria

    Redox Biology, Vol. 46

  2. Nadph-oxidase, rho-kinase and autophagy mediate the (Pro)renin-induced pro-inflammatory microglial response and enhancement of dopaminergic neuron death

    Antioxidants, Vol. 10, Núm. 9

2020

  1. Interactions Between the Serotonergic and Other Neurotransmitter Systems in the Basal Ganglia: Role in Parkinson’s Disease and Adverse Effects of L-DOPA

    Frontiers in Neuroanatomy, Vol. 14

  2. Rho kinase inhibitor fasudil reduces l-DOPA-induced dyskinesia in a rat model of Parkinson's disease

    British Journal of Pharmacology, Vol. 177, Núm. 24, pp. 5622-5641

2017

  1. Percutaneous Coronary Intervention and Cardiac Surgery in Cancer Patients

    Anticancer Treatments and Cardiotoxicity: Mechanisms, Diagnostic and Therapeutic Interventions (Elsevier Inc.), pp. 357-362

2016

  1. El riesgo de eventos cardiovasculares tras un evento coronario agudo persiste elevado a pesar de la revascularización, especialmente durante el primer año

    Revista Espanola de Cardiologia, Vol. 69, Núm. 1, pp. 11-18

  2. RETRACTED ARTICLE: Long-term mortality prediction of CHA2DS2VASc and HATCH scores in a cohort of patients with typical atrial flutter

    Clinical Research in Cardiology, Vol. 105, Núm. 4, pp. 377

2015

  1. Comparison between CHA2DS2-VASc and the new R2CHADS2 and ATRIA scores at predicting thromboembolic event in non-anticoagulated and anticoagulated patients with non-valvular atrial fibrillation

    BMC Cardiovascular Disorders, Vol. 15, Núm. 1

  2. Evaluation of SAMe-TT<inf>2</inf>R<inf>2</inf> risk score for predicting the quality of anticoagulation control in a real-world cohort of patients with non-valvular atrial fibrillation on vitamin-K antagonists

    Europace, Vol. 17, Núm. 5, pp. 711-717

  3. Impacto de la fibrilación ventricular que complica el curso de un síndrome coronario agudo en la incidencia a largo plazo de muerte súbita cardiaca

    Revista Espanola de Cardiologia, Vol. 68, Núm. 10, pp. 878-884

  4. Long-term outcome prediction of CHA2DS2VASc and HATCH scores in a cohort of patients with typical atrial flutter

    International Journal of Cardiology, Vol. 199, pp. 426-428

  5. Pronóstico a largo plazo de pacientes con infarto agudo de miocardio sin elevación del segmento ST y arterias coronarias sin estenosis significativa

    Revista Espanola de Cardiologia, Vol. 68, Núm. 9, pp. 777-784

  6. Risk stratification for the development of heart failure after acute coronary syndrome at the time of hospital discharge: Predictive ability of GRACE risk score

    Journal of Cardiology, Vol. 66, Núm. 3, pp. 224-231

  7. ¿en la era actual existe beneficio pronóstico del tratamiento con bloqueadores beta tras un síndrome coronario agudo con función sistólica conservada?

    Revista Espanola de Cardiologia, Vol. 68, Núm. 7, pp. 585-591

2014

  1. Comparative evaluation of HAS-BLED and ATRIA scores by investigating the full potential of their bleeding prediction schemes in non-valvular atrial fibrillation patients on vitamin-K antagonists

    International Journal of Cardiology, Vol. 176, Núm. 3, pp. 1259-1261

  2. Contrast-induced nephropathy and bleeding: A bidirectional link with prognostic value in acute coronary syndrome

    International Journal of Cardiology, Vol. 176, Núm. 1, pp. 235-236

  3. Is 6-month GRACE risk score a useful tool to predict stroke after an acute coronary syndrome?

    Open Heart, Vol. 1, Núm. 1

  4. Relative performance of three formulas to assess renal function at predicting in-hospital hemorrhagic complications in an acute coronary syndrome population. What does the new CKD-EPI formula provide?

    European Heart Journal: Acute Cardiovascular Care, Vol. 3, Núm. 3, pp. 237-245